Skip to main content
    M

    Merit Medical Systems Inc (MMSI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $86.35
    -0.28 (-0.32%)

    Market Cap: $5.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Merit Medical Systems Inc (MMSI) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Merit Medical Systems reported revenue of $1.52B for the fiscal year ended Dec 31, 2025, up 11.8% from the year before. That year, net income was $128.49M with a net margin of 8.5%, operating cash flow was $297.37M and free cash flow was $215.66M. The quarter ended Sep 30, 2026 had revenue of $416.24M and net income of $42.31M.

    Revenue and Margins

    The operating margin was 12.2% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $603.84M, a compound annual rate of 10.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.52B+11.8%48.7%12.2%8.5%
    Dec 2024$1.36B+7.9%47.4%11.5%8.9%
    Dec 2023$1.26B+9.2%46.4%9.9%7.5%
    Dec 2022$1.15B+7.1%45.1%7.6%6.5%
    Dec 2021$1.07B+11.5%45.2%5.7%4.5%
    Dec 2020$963.88M-3.1%41.6%-0.2%-1.0%
    Dec 2019$994.85M+12.7%43.5%1.6%0.5%
    Dec 2018$882.75M+21.3%44.7%6.6%4.8%
    Dec 2017$727.85M+20.5%44.8%4.5%3.8%
    Dec 2016$603.84MN/A43.9%5.8%3.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 6.8% from the year before. In the quarter ended Sep 2026, net income rose 52.5% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.52B$1.36B$1.26B$1.15B$1.07B$963.88M$994.85M$882.75M$727.85M$603.84M
    Cost of revenue$777.64M$713.18M$673.49M$631.88M$589.42M$562.70M$562.49M$487.98M$401.60M$338.81M
    Gross profit$738.27M$643.33M$583.87M$519.10M$485.33M$401.18M$432.37M$394.77M$326.25M$265.02M
    Research and development$97.35M$87.47M$84.28M$82.18M$71.25M$57.79M$66.14M$60.18M$63.54M$45.69M
    Operating income$184.72M$155.69M$123.94M$87.56M$60.92M-$1.56M$15.43M$58.62M$33.07M$34.88M
    Net income$128.49M$120.36M$94.41M$74.52M$48.45M-$9.84M$5.45M$42.02M$27.52M$20.12M
    EBITDA$322.53M$276.38M$228.05M$180.62M$154.69M$103.45M$119.83M$128.89M$97.36M$78.64M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$416.24M$418.84M$381.88M$393.94M$384.16M$382.46M$355.35M$355.16M$339.85M$338.00M$323.51M$324.51M
    Gross profit$200.63M$215.17M$184.80M$195.35M$186.41M$184.49M$172.02M$172.98M$157.53M$161.10M$151.72M$150.53M
    Operating income$58.76M$60.40M$44.16M$54.20M$42.61M$46.88M$41.03M$36.56M$37.26M$45.95M$35.92M$33.61M
    Net income$42.31M$38.80M$40.99M$38.01M$27.75M$32.58M$30.15M$27.95M$28.44M$35.73M$28.24M$27.63M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $744.91M exceeded cash and equivalents by $298.51M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$2.69B$2.42B$2.33B$1.66B$1.65B$1.66B$1.76B$1.62B$1.11B$942.80M
    Current assets$1.04B$923.77M$1.11B$529.08M$482.21M$429.71M$454.54M$429.83M$316.12M$243.42M
    Cash and equivalents$446.40M$376.71M$587.04M$58.41M$67.75M$56.92M$44.32M$67.36M$32.34M$19.17M
    Total liabilities$1.10B$1.04B$1.12B$519.57M$608.50M$705.82M$807.38M$687.24M$435.48M$444.61M
    Short-term debt$10.88M$10.33M$12.09M$11.25M$8.44M$7.50M$7.50M$22.00M$19.46M$10.00M
    Long-term debt$734.04M$729.55M$823.01M$186.76M$234.40M$343.72M$431.98M$373.15M$259.01M$314.37M
    Shareholder equity$1.58B$1.38B$1.20B$1.14B$1.04B$958.58M$949.94M$932.77M$676.33M$498.19M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.92B$2.86B$2.72B$2.69B$2.63B$2.59B$2.47B$2.42B$2.38B$2.37B$2.33B$2.33B
    Total liabilities$1.18B$1.18B$1.09B$1.10B$1.10B$1.10B$1.04B$1.04B$1.05B$1.09B$1.09B$1.12B
    Cash and equivalents$503.55M$448.70M$488.08M$448.50M$392.46M$341.82M$395.53M$376.71M$523.13M$636.66M$581.92M$587.04M
    Shareholder equity$1.74B$1.68B$1.63B$1.58B$1.53B$1.49B$1.43B$1.38B$1.32B$1.28B$1.24B$1.20B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 72.5% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$297.37M$220.80M$145.15M$114.29M$147.23M$165.27M$77.81M$86.53M$62.73M$53.60M
    Capital expenditures$81.72M$35.14M$34.29M$45.03M$27.94M$45.99M$78.17M$63.32M$38.62M$32.84M
    Free cash flow$215.66M$185.66M$110.86M$69.26M$119.29M$119.28M-$360.00K$23.21M$24.10M$20.76M
    Dividends paidN/AN/AN/A$2.47M$576.00K$866.00KN/A$0$0$0
    Share repurchasesN/AN/AN/AN/AN/AN/AN/A$366.00K$816.00K$0
    Investing cash flow-$247.39M-$368.65M-$175.35M-$57.40M-$37.16M-$58.65M-$134.48M-$378.82M-$146.76M-$159.11M
    Financing cash flow$16.00M-$60.01M$559.27M-$60.26M-$98.44M-$95.71M$33.53M$328.28M$96.52M$121.09M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$65.27M$69.28M$40.68M$98.51M$74.98M$83.31M$40.57M$68.74M$47.33M$68.51M$36.22M$62.25M
    Capital expenditures$12.35M$17.33M$16.01M$24.46M$22.44M$13.75M$21.06M$3.47M$9.36M$10.63M$11.68M$7.14M
    Free cash flow$52.93M$51.95M$24.67M$74.05M$52.54M$69.56M$19.51M$65.27M$37.97M$57.88M$24.53M$55.11M
    Last 12 quarters

    Frequently Asked Questions About MMSI

    What is Merit Medical Systems' annual revenue?

    Merit Medical Systems reported revenue of $1.52B for the fiscal year ended Dec 31, 2025.

    How fast is Merit Medical Systems' revenue growing?

    Revenue was up 11.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.6%.

    Is Merit Medical Systems profitable?

    Yes. Merit Medical Systems reported net income of $128.49M for the fiscal year ended Dec 31, 2025, with a net margin of 8.5%.

    How much free cash flow does MMSI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $297.37M minus capital expenditures of $81.72M produced free cash flow of $215.66M.

    How much debt does Merit Medical Systems have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $734.04M, short-term debt of $10.88M and cash and equivalents of $446.40M.